108
Participants
Start Date
June 6, 2017
Primary Completion Date
December 19, 2019
Study Completion Date
December 19, 2019
Recombinant Human Prourokinase
The drug is used for intravenous thrombolysis therapy
Alteplase
The drug is used for intravenous thrombolysis therapy
Fuwai Hospital, Beijing
Anzhen Hospital, Capital Medical University, Beijing
Beijing Tongren Hospital,Capital Medical University, Beijing
The Second Affiliated Hospital of Harbin Medical University, Harbin
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Wuhan Asia Heart Hospital, Wuhan
Xiangya Hospital, Central South University, Changsha
Jiangsu Province Hospital, Nanjing
Nanjing First Hospital, Nanjing
The First Affiliated Hospital of Nanchang University, Nanchang
The First Hospital of Jilin University, Changchun
The First Hospital of China Medical University, Shenyang
General Hospital of Ningxia Medical University, Yinchuan
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
West China Hospital of Sichuan University, Chengdu
Tianjin Chest Hospital, Tianjin
Sir Run Run Shaw Hospital affiliated with the Zhejiang University School of Medicine, Hangzhou
Tasly Biopharmaceuticals Co., Ltd.
INDUSTRY